pI: 6.1668 |
Length (AA): 331 |
MW (Da): 37763 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 325 | 1f05 (A) | 11 | 331 | 57.00 | 0 | 1 | 1.77937 | -1.67 |
1 | 331 | 3hjz (A) | 1 | 328 | 50.00 | 0 | 1 | 1.7155 | -1.58 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127238)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G12230 | transaldolase-like protein |
Brugia malayi | Bm1_04195 | Transaldolase |
Candida albicans | CaO19.11849 | Transaldolase |
Candida albicans | CaO19.4371 | Transaldolase |
Caenorhabditis elegans | CELE_Y24D9A.8 | Protein Y24D9A.8, isoform B |
Chlamydia trachomatis | CT_313 | transaldolase |
Dictyostelium discoideum | DDB_G0280909 | hypothetical protein |
Drosophila melanogaster | Dmel_CG2827 | CG2827 gene product from transcript CG2827-RA |
Escherichia coli | b3946 | fructose-6-phosphate aldolase 2 |
Escherichia coli | b2464 | transaldolase A |
Escherichia coli | b0008 | transaldolase B |
Escherichia coli | b0825 | fructose-6-phosphate aldolase 1 |
Echinococcus granulosus | EgrG_000092800 | transaldolase |
Echinococcus multilocularis | EmuJ_000092800 | transaldolase |
Homo sapiens | ENSG00000177156 | transaldolase 1 |
Leishmania braziliensis | LbrM.16.0750 | transaldolase, putative |
Leishmania donovani | LdBPK_160760.1 | transaldolase, putative |
Leishmania infantum | LinJ.16.0760 | transaldolase, putative |
Leishmania major | LmjF.16.0760 | transaldolase, putative |
Leishmania mexicana | LmxM.16.0760 | transaldolase, putative |
Loa Loa (eye worm) | LOAG_02901 | transaldolase |
Mus musculus | ENSMUSG00000025503 | transaldolase 1 |
Neospora caninum | NCLIV_030290 | transaldolase, putative |
Oryza sativa | 4344683 | Os08g0154300 |
Onchocerca volvulus | OVOC3446 | Transaldolase homolog |
Saccharomyces cerevisiae | YGR043C | sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate transaldolase NQM1 |
Saccharomyces cerevisiae | YLR354C | sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate transaldolase TAL1 |
Schistosoma japonicum | Sjp_0213130 | ko:K00616 transaldolase [EC2.2.1.2], putative |
Schistosoma mansoni | Smp_070600 | transaldolase |
Schmidtea mediterranea | mk4.008991.00 | |
Schmidtea mediterranea | mk4.010083.00 | Probable transaldolase |
Schmidtea mediterranea | mk4.035731.04 | Probable transaldolase |
Schmidtea mediterranea | mk4.035731.03 | |
Trypanosoma brucei gambiense | Tbg972.8.5600 | transaldolase, putative |
Trypanosoma brucei | Tb927.8.5600 | transaldolase, putative |
Trypanosoma congolense | TcIL3000_0_10000 | transaldolase, putative |
Trypanosoma cruzi | TcCLB.503477.20 | transaldolase, putative |
Trypanosoma cruzi | TcCLB.507889.10 | transaldolase, putative |
Toxoplasma gondii | TGME49_229360 | transaldolase |
Trichomonas vaginalis | TVAG_272910 | transaldolase total2, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0686 | translaldolase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.5600 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.5600 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.5600 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.5600 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0008 | Escherichia coli | non-essential | goodall |
b0825 | Escherichia coli | non-essential | goodall |
b2464 | Escherichia coli | non-essential | goodall |
b3946 | Escherichia coli | non-essential | goodall |
TGME49_229360 | Toxoplasma gondii | Probably non-essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.